Cargando…

A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' Disease

Background: Patients with Graves' disease are commonly treated with radioiodine. There remains controversy over whether the aim of treatment should be to achieve euthyroidism or hypothyroidism, and whether treatments should be administered with standard levels of radioactivity or personalized a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taprogge, Jan, Gape, Paul M.D., Carnegie-Peake, Lily, Murray, Iain, Gear, Jonathan I., Leek, Francesca, Hyer, Steve L., Flux, Glenn D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2021
Materias:	Thyroid Radiology and Nuclear Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721505/ https://www.ncbi.nlm.nih.gov/pubmed/34598656 http://dx.doi.org/10.1089/thy.2021.0302

Ejemplares similares

Quantification and dosimetry of small volumes including associated uncertainty estimation
por: Carnegie-Peake, Lily, et al.
Publicado: (2022)

The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
por: Taprogge, Jan, et al.
Publicado: (2023)

Radioiodine Therapy Does Not Change the Atherosclerotic Burden of the Carotid Arteries
por: la Cour, Jeppe Lerche, et al.
Publicado: (2016)

SAT-417 Personalized Treatment Planning for Radioiodine Therapy of Graves’ Disease;The Collar Therapy Indicator(CoTI)
por: Santhanam, Prasanna, et al.
Publicado: (2020)

Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
por: Taprogge, Jan, et al.
Publicado: (2023)

ODP531 Worsening of pretibial myxedema following repeated doses of radioiodine treatment in a patient with hyperthyroid Graves’ disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

Characterisation of the attenuation properties of 3D-printed tungsten for use in gamma camera collimation
por: Gear, Jonathan I., et al.
Publicado: (2019)

SAT525 Long-Term Outcomes in Stage I Thyroid Cancer Without Radioiodine Remnant Ablation
por: Mubeen, Faiza, et al.
Publicado: (2023)

Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project
por: Taprogge, Jan, et al.
Publicado: (2020)

Hurthle Cells Adenoma With Distant Metastases Refractory to Radioiodine
por: Rosario, Pedro Weslley, et al.
Publicado: (2021)

FRI534 Influence Of Radioiodine Therapy Of Huge Thyroid Goiter On The Development Of Autoimmune Thyroid Disease In Retreated Patents
por: Skoczylas, Aleksander, et al.
Publicado: (2023)

A Grave Turn on Hashimoto’s Thyroiditis - A Case Series on Four Patients With Autoimmune Hypothyroidism that Converted to Grave’s Disease
por: Lee, Michelle N, et al.
Publicado: (2021)

A Grave Initial Presentation of Graves’ Disease in a Patient With Moyamoya
por: Clutter, Courtney, et al.
Publicado: (2021)

Graves Disease in Infancy
por: Beliard, Kara A, et al.
Publicado: (2021)

Uncertainty analysis of tumour absorbed dose calculations in molecular radiotherapy
por: Finocchiaro, Domenico, et al.
Publicado: (2020)

MON-LB76 Impact of Age on Survival and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Cancer Patients
por: Buffet, Camille
Publicado: (2020)

Presentation and Outcome of Severe Graves’ Disease
por: Babu, Priya Mohan, et al.
Publicado: (2021)

SUN-622 Graves Disease Triggered by Lobectomy for Thyroid Cancer
por: Woods, Allison, et al.
Publicado: (2019)

A Rare Phenomenon of Hashimotos Thyroiditis Converting to Graves Disease
por: Caseja, Ahl Jeffrey, et al.
Publicado: (2021)

PSAT358 Graves’ Disease Complicated by Post-Operative Graves’ Ophthalmopathy and Pretibial Myxedema
por: Bowens, Brendan, et al.
Publicado: (2022)

MON-LB87 Recombinant Human TSH vs Thyroid Hormone Withdrawal Preparation for Radioiodine Ablation in Pediatric Differentiated Thyroid Cancer
por: Schumm, Max A, et al.
Publicado: (2020)

SAT-410 Long Term Evaluation of TSH Receptor Antibodies and Thyroid Stimulating Immunoglobulin After Radioiodine Therapy for Thyrotoxicosis
por: Marui, Suemi, et al.
Publicado: (2020)

SAT-603 Graves' Disease and an Anterior Mediastinal Mass
por: Robbins, D'lorah, et al.
Publicado: (2019)

Dosimetry-based treatment for Graves’ disease
por: Hyer, Steve L., et al.
Publicado: (2018)

Successful Management of Hyperthyroidism With Lithium and Radioiodine in a Patient With Previous Methimazole-Induced Agranulocytosis
por: Fantin, Esther H, et al.
Publicado: (2021)

SUN-LB097 Thyroid Hormone Resistance Simulating Graves Disease
por: Ballestas-Revollo, Martha, et al.
Publicado: (2019)

SAT-588 Unique Presentation of Postpartum Thyroiditis with Features of Graves' Disease
por: Havranova, Jana, et al.
Publicado: (2019)

SUN-492 Treatment of Uncontrolled Graves’ Disease Reveals Underlying Thyroiditis
por: Sheung, Nicole, et al.
Publicado: (2020)

Incidental Diffuse Sclerosing Variant Papillary Thyroid Cancer in Grave’s Disease
por: Canales, Nicolle, et al.
Publicado: (2021)

EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
por: Gear, Jonathan I., et al.
Publicado: (2018)

MON-558 Radioiodine Is Not Associated with Quality of Life Outcomes in Early Stage Thyroid Cancer Survivors, a Matched-Pair Analysis.
por: Chow, Kimberly, et al.
Publicado: (2019)

OR28-03 Drug Repurposing Identifies Inhibitors of the Proteostasis Network to Augment Radioiodine Uptake in Combinatorial Approaches Targeting Thyroid Cancer
por: Read, Martin L, et al.
Publicado: (2020)

MON-443 SPECT/CT Localization of Incidental Diverticular Bleed After Radioiodine (i(131)) Therapy for Metastatic Thyroid Cancer
por: Doshi, Sejal B, et al.
Publicado: (2020)

PSAT243 Late Versus Early Administration of Radioiodine Therapy for Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis
por: Lincango Naranjo, Eddy P, et al.
Publicado: (2022)

The Grave Hematologic and Hepatic Effects of Hyperthyroidism
por: Ahmad, Sara Miriam, et al.
Publicado: (2021)

An Unusual Etiology of Graves’ Disease: Alemtuzumab
por: Santiago Carrion, Ada Marie, et al.
Publicado: (2021)

Graves’ Disease Induced Severe Hypercalcemia
por: Lugo Lopez, Zahira Marie, et al.
Publicado: (2021)

Effectiveness of Different Thyroid Stimulating Hormone Thresholds for Thyroid Hormone Withdrawal - Aided Radioiodine Ablation in Patients With Differentiated Thyroid Cancer: A Systematic Review and Meta - Analysis
por: Rojas, Tatiana, et al.
Publicado: (2021)

SAT-581 Graves' Disease and Hashimoto's Thyroiditis: Two Ends of a Spectrum
por: Morselli, Lisa, et al.
Publicado: (2019)

SAT-415 Clinical Performance of Thyroid-Stimulating Immunoglobulin for Graves′ Disease Diagnosis
por: Marui, Suemi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kbo894dfh9km23pnnk5j357qik